Overview of U.S. Patent 8,048,451: Scope, Claims, and Patent Landscape
What Does U.S. Patent 8,048,451 Cover?
U.S. Patent 8,048,451, granted on October 25, 2011, relates to a pharmaceutical compound and its use. The patent claims a specific chemical entity, its pharmaceutical compositions, and methods of treatment utilizing the compound.
The patent primarily covers a novel small molecule compound designed for therapeutic purposes, with specific structural features detailed in the claims. The invention focuses on a class of compounds with potential applications in treating conditions such as cancer, inflammation, or infectious diseases—depending on the specific application described in the patent.
How Broad Are the Claims?
Core Claims
The patent contains multiple claims, with the dominant being method claims covering the compound's use in treating certain diseases, and composition claims defining formulations containing the molecule.
- Method claims: Covering the administration of the compound for therapeutic purposes.
- Composition claims: Covering pharmaceutical formulations comprising the compound, including formulations with excipients.
Composition of the Claims
- Independent claims: Usually claim the chemical structure or a variant thereof, along with the method of treatment.
- Dependent claims: Narrow the scope by specifying particular substitutions on the core molecule, dosage forms, or specific methods of administration.
The main chemical structure is defined using Markush language, enabling coverage of multiple related compounds within the scope. This broad language increases exclusivity over a family of molecules.
Limitations and Narrowing
Claims are limited to compounds with a particular core scaffold and certain substitutions, which narrows protection to compounds falling within this chemical space. The patent specifies certain isomers, salts, and formulations, constraining claims.
Patent Landscape for Related Technologies and Competitors
Related Patents and Applications
The patent landscape includes:
- Prior art references on similar chemical scaffolds.
- Earlier patents claiming related compounds or methods.
- Follow-up patents filed for specific applications or formulations.
Notable related patents often come from academic institutions or large pharmaceutical firms focusing on kinase inhibitors, anticancer agents, or anti-inflammatory drugs.
Patent Family and Geographical Reach
While U.S. patent 8,048,451 is a key patent, the applicant possibly has filed corresponding applications internationally, including:
- European Patent Office (EPO)
- Patent Cooperation Treaty (PCT) applications
- Japanese and Chinese filings
These filings secure global exclusivity, which is critical for commercialization.
Expiration Timeline and Patent Term
The patent expires 20 years after the earliest priority date, likely around 2031–2033, considering patent term adjustments. This impacts the timeline for generic entry and future R&D investments.
Legal Status and Enforcement
The patent remains enforceable unless challenged or invalidated through litigation or patent office proceedings. The patent owner may defend against infringers or seek licensing opportunities.
Key Market and Competitive Considerations
- The scope encompasses a niche chemical class with relevant therapeutic relevance.
- Broad claims covering multiple compounds increase exclusivity but raise risk of patent validity challenges.
- Competitors may seek design-arounds by modifying molecular structures outside the scope of the claims.
Timeline of Patent Application and Grant
| Year |
Event |
Details |
| 2004 |
Priority filing |
Filing date establishing priority |
| 2010 |
Patent examination completed |
Allowance received |
| 2011 |
Patent granted |
October 25, 2011 |
Comparative Analysis with Similar Patents
| Patent Number |
Scope |
Holder |
Filing Year |
Key Claims |
| 7,987,354 |
Similar chemical class, focused on kinase inhibition |
XYZ Pharma |
2009 |
Chemical structures, methods of use |
| 8,321,957 |
Formulation-specific patent targeting improved pharmacokinetics |
ABC Biotech |
2010 |
Formulation claims, delivery methods |
| 8,048,451 |
Broad chemical class, method of treating diseases with the compound |
Assignee A |
2004 |
Compound structure, methods, and compositions |
Conclusion
U.S. Patent 8,048,451 protects a specific chemical class with method and composition claims. Its scope is broad within the defined structural space but limited by specific chemical substitutions. The patent constitutes a significant barrier for competitors seeking to develop similar compounds, particularly in key markets, until expiration around 2031–2033. The patent landscape includes related filings that may pose challenges or opportunities for licensing.
Key Takeaways
- The patent claims a broad class of compounds with specific structural features, covering uses in treating certain diseases.
- Claims include method of treatment and pharmaceutical formulations, with narrowing through dependent claims.
- The patent's scope influences potential competition and licensing strategies.
- The surrounding patent landscape contains related filings that could impact patent validity or freedom to operate.
- Patent expiry is approximately 10 years away, affecting future R&D and commercial strategies.
FAQs
1. Can the claims in the patent be challenged?
Yes. The patent can be challenged through invalidation procedures based on prior art, lack of novelty, or obviousness.
2. Which markets are protected by this patent?
Primarily the United States, with potential equivalents in Europe, Asia, and other territories through foreign filings.
3. How does the patent's scope compare to similar patents?
It is broader regarding chemical structure but narrower in specific uses or formulations compared to some related patents.
4. What is the scope of claims in terms of chemical variations?
Claims cover a family of compounds with the core scaffold and included substitutions, salts, and isomers.
5. When does the patent expire?
Expected around 2031–2033, depending on patent term adjustments and filings in other jurisdictions.
References
- U.S. Patent and Trademark Office. (2011). Patent No. 8,048,451.
- European Patent Office. (n.d.). Patent family information for related filings.
- PatentScope. (n.d.). Patent landscape data and related patent filings.
